Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Hepion Pharmaceuticals, Inc. HEPA

Full chart Compare
Set alert

Price alert · HEPA

All alert types
0.12 USD +0.01 (+6.09%)

At closeNov 6, 2026, 4:00 PM EST

0.17 +0.05 +38.44%

After hours · Nov 6, 4:00 PM ET

0.1046 Day range 0.1325
0.034 52-week range 0.22
YTD
+103.33%
1 year
+43.53%

Financial health

Altman Z-Score

-182.92 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 5

Valuation

P/E -0.1×
FY 2016: -114×FY 2017: -1.9×FY 2018: -0.2×FY 2019: -0.9×FY 2020: -1.0×FY 2021: -2.4×FY 2022: -0.5×FY 2023: -0.3×FY 2024: -0.2×FY 2025: -0.1×
FY 2016 5y median -0.3× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 0.2×
FY 2016: 187×FY 2017: 7.5×FY 2018: 1.8×FY 2019: 0.7×FY 2020: 0.5×FY 2021: 0.9×FY 2022: 0.5×FY 2023: 1.8×FY 2024: -1.6×FY 2025: 0.2×
FY 2016 5y median 0.5× FY 2025
P/FCF -0.2×
FY 2016: -88.1×FY 2017: -3.4×FY 2018: -0.2×FY 2019: -1.4×FY 2020: -1.3×FY 2021: -2.6×FY 2022: -0.7×FY 2023: -0.3×FY 2024: -0.2×FY 2025: -0.2×
FY 2016 5y median -0.3× FY 2025
EV/EBITDA 0.3×
FY 2016: -79.8×FY 2017: -1.1×FY 2018: -0.2×FY 2019: 0.3×FY 2020: 0.9×FY 2021: 0.3×FY 2022: 0.6×FY 2023: 0.0×FY 2024: -0.4×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -579.5%
FY 2016: -1.1%FY 2017: -29.5%FY 2018: -430.8%FY 2019: -69.6%FY 2020: -76.7%FY 2021: -39.1%FY 2022: -152.8%FY 2023: -317.9%FY 2024: -630.5%FY 2025: -579.5%
FY 2016 5y median -317.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -310.3%
FY 2016: -164.4%FY 2017: -405.7%FY 2018: -478.4%FY 2019: -45.1%FY 2020: -50.2%FY 2021: -35.2%FY 2022: -84.6%FY 2023: -672.0%FY 2024: 708.0%FY 2025: -310.3%
FY 2016 5y median -84.6% FY 2025
ROIC -147.4%
FY 2016: -120.7%FY 2017: -193.2%FY 2018: -203.7%FY 2019: -35.7%FY 2020: -45.5%FY 2021: -31.8%FY 2022: -81.2%FY 2023: -371.9%FY 2024: -1152.8%FY 2025: -147.4%
FY 2016 5y median -147.4% FY 2025
ROA -269.6%
FY 2016: -81.0%FY 2017: -133.5%FY 2018: -115.4%FY 2019: -34.1%FY 2020: -41.8%FY 2021: -31.6%FY 2022: -70.0%FY 2023: -270.4%FY 2024: -817.5%FY 2025: -269.6%
FY 2016 5y median -269.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 78.5%
FY 2016: -1.0%FY 2017: -0.1%FY 2018: 30.6%FY 2019: 46.8%FY 2020: -159.3%FY 2021: -50.9%FY 2022: -49.6%FY 2023: -6.5%FY 2024: 60.1%FY 2025: 78.5%
FY 2016 FY 2025
EPS (diluted) 99.2%
FY 2016: 99.0%FY 2017: -3053.6%FY 2018: 8.5%FY 2019: 93.7%FY 2020: 65.6%FY 2021: 77.9%FY 2022: -27.8%FY 2023: -3.6%FY 2024: 82.6%FY 2025: 99.2%
FY 2016 FY 2025
Free Cash Flow 82.0%
FY 2016: -15.9%FY 2017: 57.2%FY 2018: -90.6%FY 2019: 51.3%FY 2020: -113.4%FY 2021: -92.9%FY 2022: -11.6%FY 2023: -16.9%FY 2024: 55.5%FY 2025: 82.0%
FY 2016 FY 2025

Financial Health

Current Ratio 10.3×
FY 2016: 4.5×FY 2017: 2.3×FY 2018: 1.0×FY 2019: 8.9×FY 2020: 9.1×FY 2021: 11.9×FY 2022: 7.2×FY 2023: 3.3×FY 2024: 0.5×FY 2025: 10.3×
FY 2016 5y median 7.2× FY 2025
Quick Ratio 10.3×
FY 2016: 4.5×FY 2017: 2.3×FY 2018: 1.0×FY 2019: 8.9×FY 2020: 9.1×FY 2021: 11.9×FY 2022: 7.2×FY 2023: 3.3×FY 2024: 0.5×FY 2025: 10.3×
FY 2016 5y median 7.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.7×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -1.6×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 0.6×FY 2017: 0.3×FY 2018: 0.1×FY 2019: 1.7×FY 2020: 2.0×FY 2021: 2.8×FY 2022: 1.1×FY 2023: 0.3×FY 2024: -0.2×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -171×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -43.0×FY 2019: -14.0×FY 2020: -645×FY 2021: -3432×FY 2022: -4475×FY 2023: -5119×FY 2024: -15.5×FY 2025: -171×
FY 2016 5y median -3432× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31